Literature DB >> 15377170

Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Karen Berman1, Henry Brodaty.   

Abstract

In this article, we review the evidence that tocopherol (vitamin E) may have a role to play in the prevention and treatment of Alzheimer's disease and other neurological diseases. The theoretical rationale for the effectiveness of tocopherol as treatment and/or prevention of Alzheimer's disease is based on its antioxidant properties. Results from animal and in vitro studies provide evidence to support use of tocopherol for prevention and treatment of degenerative neurological diseases. Furthermore, several, but not all, epidemiological, cross-sectional, prospective studies indicate that tocopherol may have protective effects in Alzheimer's disease, although dietary and supplemental forms of the vitamin may differ in their efficacy. Mixed results have been obtained from clinical trials. Evidence of the use of tocopherol as a protective measure or as therapy in neurological diseases other than Alzheimer's disease is less compelling. To date, there are no clear-cut answers as to whether tocopherol is worth prescribing, but current clinical practice favours its use in the treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377170     DOI: 10.2165/00023210-200418120-00005

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  123 in total

1.  Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

Authors:  K H Masaki; K G Losonczy; G Izmirlian; D J Foley; G W Ross; H Petrovitch; R Havlik; L R White
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

Review 2.  Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention.

Authors:  J A Joseph; N A Denisova; D Bielinski; D R Fisher; B Shukitt-Hale
Journal:  Mech Ageing Dev       Date:  2000-07-31       Impact factor: 5.432

3.  Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates.

Authors:  G Escames; J M Guerrero; R J Reiter; J J Garcia; A Munoz-Hoyos; G G Ortiz; C S Oh
Journal:  Neurosci Lett       Date:  1997-07-25       Impact factor: 3.046

4.  Chronic antioxidant treatment improves the cognitive performance of aged rats.

Authors:  D J Socci; B M Crandall; G W Arendash
Journal:  Brain Res       Date:  1995-09-25       Impact factor: 3.252

Review 5.  Vitamin E: the radical protector.

Authors:  R Wolf; D Wolf; V Ruocco
Journal:  J Eur Acad Dermatol Venereol       Date:  1998-03       Impact factor: 6.166

6.  Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB.

Authors:  C Behl
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

7.  Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.

Authors:  E Martignoni; F Blandini; L Godi; S Desideri; C Pacchetti; F Mancini; G Nappi
Journal:  Free Radic Biol Med       Date:  1999-08       Impact factor: 7.376

Review 8.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

9.  Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

Authors:  J D Adams; L K Klaidman; I N Odunze; H C Shen; C A Miller
Journal:  Mol Chem Neuropathol       Date:  1991-06

10.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01
View more
  9 in total

1.  High-throughput determination of vitamin E in extra virgin olive oil by paper spray tandem mass spectrometry.

Authors:  Lucia Bartella; Leonardo Di Donna; Anna Napoli; Giovanni Sindona; Fabio Mazzotti
Journal:  Anal Bioanal Chem       Date:  2019-03-21       Impact factor: 4.142

2.  Chemosensitization Effect of Seabuckthorn (Hippophae rhamnoides L.) Pulp Oil via Autophagy and Senescence in NSCLC Cells.

Authors:  Uyanga Batbold; Jun-Jen Liu
Journal:  Foods       Date:  2022-05-23

Review 3.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

4.  Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Ralph W Kuncl; Stephanie J Weinstein; Nea Malila; Jarmo Virtamo; Demetrius Albanes
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-01-04       Impact factor: 4.092

Review 5.  Prevention of Alzheimer disease. Encouraging evidence.

Authors:  Monica Zavaloni Scalco; Robert van Reekum
Journal:  Can Fam Physician       Date:  2006-02       Impact factor: 3.275

6.  Protective effect of some vitamins against the toxic action of ethanol on liver regeneration induced by partial hepatectomy in rats.

Authors:  Carlett Ramírez-Farías; Eduardo Madrigal-Santillán; José Gutiérrez-Salinas; Nidia Rodríguez-Sánchez; Maricela Martínez-Cruz; Ilse Valle-Jones; Ingrid Gramlich-Martínez; Alejandra Hernández-Ceruelos; José A Morales-Gonzaléz
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 7.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01

Review 8.  Treatment of Alzheimer's disease in Brazil: I. Cognitive disorders.

Authors:  Francisco de Assis Carvalho do Vale; Ylmar Corrêa Neto; Paulo Henrique Ferreira Bertolucci; João Carlos Barbosa Machado; Delson José da Silva; Nasser Allam; Márcio Luiz Figueredo Balthazar
Journal:  Dement Neuropsychol       Date:  2011 Jul-Sep

9.  Bioactive Properties of Tabebuia impetiginosa-Based Phytopreparations and Phytoformulations: A Comparison between Extracts and Dietary Supplements.

Authors:  Tânia C S P Pires; Maria Inês Dias; Ricardo C Calhelha; Ana Maria Carvalho; Maria-João R P Queiroz; Lillian Barros; Isabel C F R Ferreira
Journal:  Molecules       Date:  2015-12-21       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.